Speaker Profile

Ph.D., CEO, GeneScape

Karen Malone is dedicated closing the gap in drug development strategies for innovative, personalized therapies, by mapping the unmet need for inherited rare, ultra-rare, and orphan diseases. She founded GeneScape® to help inform drug development planning, with the goal of accelerating advanced therapeutics to these patients. GeneScape® leverages the latest in large-scale human genetic diversity data and machine learning tools to provide actionable data and reliable patient models to address some of the most challenging rare diseases. Dr. Malone is a molecular biologist and geneticist with a track-record of over 15 years of drug development experience, including prior scientific roles at Janssen Pharmaceuticals. Her work has covered the entire development path from discovery to pivotal trials, and new product planning. She has supported the development of a range of therapeutic modalities including genetic therapies for numerous indications and published more than 11 scientifically peer-reviewed papers.

GeneScape: Mapping Inherited Rare Disease Patient Populations
Dr. Malone will present GeneScape’s platform and recent examples of how their research has informed various programs by 1) quantifying the scale of unmet need, 2) estimating specific patient subsets, 3) identifying highest probability regions for finding patients, and 5) understanding the importance of patient genetic diversity within specific indications.

AI and Data Sciences Showcase:

GeneScape® is specialized in epidemiology for inherited rare, ultra-rare and orphan diseases. We leverage the latest in large-scale genetic diversity data to deliver actionable insights to streamline drug development. GeneScape® is a compass to navigate and transform your programs for rare, ultra-rare and orphan diseases.

 Session Abstract – PMWC 2024 Silicon Valley

Showcase Track S1 - January 24 9.00 A.M.-4.45 P.M.,Showcase Track S1 - January 25 9.45 A.M.-4.00 P.M.,Showcase Track S1 - January 26 11.00 A.M.-3.45 P.M.

The PMWC 2024 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUL. 18TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required